Estrogen Receptor Alpha Gene Polymorphisms and Breast Cancer Risk: a Case-control Study with Meta-analysis Combined

Lu, Hong; Chen, Dong; Hu, Li-Ping; Zhou, Lian-Lian; Xu, Hui-Ying; Bai, Yong-Heng; Lin, Xiang-Yang

추천

검색

자료유형: 학술저널

저자정보: Lu, Hong (Department of Laboratory Medicine, First Affiliated Hospital of Wenzhou Medical University) Chen, Dong (Wenzhou Center of Disease Control and Prevention) Hu, Li-Ping (Department of Laboratory Medicine, First Affiliated Hospital of Wenzhou Medical University) Zhou, Lian-Lian (Department of Laboratory Medicine, First Affiliated Hospital of Wenzhou Medical University) Xu, Hui-Ying (Department of Laboratory Medicine, First Affiliated Hospital of Wenzhou Medical University) Bai, Yong-Heng (Wenzhou Key Laboratory of Surgery, First Affiliated Hospital of Wenzhou Medical University) Lin, Xiang-Yang (Department of Laboratory Medicine, First Affiliated Hospital of Wenzhou Medical University)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제14권 제11호

발행연도: 2013.1

수록면: 6,743 - 6,749 (7page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Molecular epidemiological studies have shown that gene polymorphisms of estrogen receptor alpha gene (ESR-${\alpha}$) are associated with breast cancer risk. However, previous results from many molecular studies have been inconsistent. In this study, we examined two polymorphisms (PvuII and XbaI RFLPs) of the ESR-${\alpha}$ gene in 542 breast cancer cases and 1,016 controls from China. Associations between the polymorphisms and breast cancer risk were calculated with an unconditional logistic regression model. Linkage disequilibrium and haplotypes were analyzed with the SHEsis software. In addition, we also performed a systematic meta-analysis of 24 published studies evaluating the association. No significant associations were found between the PvuII polymorphism and breast cancer risk. However, a significantly decreased risk of breast cancer was observed among carriers of the XbaI 'G' allele (age-adjusted OR = 0.80; 95% CI = 0.66- 0.97) compared with carriers of the 'A' allele. Haplotype analysis showed significantly decreased cancer risk for carriers of the 'CG' haplotype (OR = 0.79; 95% CI = 0.66- 0.96). In the systematic meta-analysis, the XbaI 'G' allele was associated with an overall significantly decreased risk of breast cancer (OR = 0.90, 95% CI = 0.82- 1.00). In addition, the PvuII 'C' allele showed a 0.96- fold decreased disease risk (95% CI = 0.92- 0.99). In subgroup analysis, an association between the PvuII 'C' and XbaI 'G' alleles and breast cancer risk was significant in Asians ('C' vs. 'T': OR = 0.93, 95% CI = 0.85- 1.00; 'G' vs. 'A': OR = 0.82, 95% CI = 0.68- 0.98), but not in Euro-Americans. Thus, our results provide evidence that ESR-${\alpha}$ polymorphisms are associated with susceptibility to breast cancer. These associations may largely depend on population characteristics and geographic location.

#Estrogen receptor #polymorphism #breast cancer #risk #meta-analysis

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요